DSIP dosage and protocol
DSIP dosage on this page comes only from published human studies, each linked to its source, with how it was given and to whom. DSIP is a nine-amino-acid peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, isolated from the cerebral venous blood of rabbits during sleep-inducing electrical stimulation of the thalamus. Its amino acid sequence was published in 1978.
What DSIP dosage is on record?
300 mcg to 4 mg in human studies9 doses on record from published human research (1, 2, 3, 4, 5, 6, 7, 8). How it was given: IV, nasal. None of these were stated as injections under the skin or into a muscle.
Checked 10 Oct 2026 against labels, PubMed and the US and Canadian regulators.
What DSIP is
DSIP is a nine-amino-acid peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, isolated from the cerebral venous blood of rabbits during sleep-inducing electrical stimulation of the thalamus. Its amino acid sequence was published in 1978. (9)
Other names and codes used in the research: delta sleep-inducing peptide, emideltide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
DSIP dosage on record
Every DSIP dosage below comes from a product label or a published human study. The grey line under each dose is the source's own wording, so you can check it. Doses from different studies are not interchangeable: look at how it was given, to whom and for how long.
| Dose | Type | How often | How long | Who |
|---|---|---|---|---|
| 25 nmol/kgFirst human study, double-blind crossover; slow intravenous infusion in the morningSource text: “DSIP was applied as slow intravenous infusions at a dosage of 25 nmol/kg in the morning.” | Human study | single dose | one day | 6 normal volunteers, four men and two women (2) |
| 25 nmol/kgChronic insomnia, single dose before night sleep; intravenousSource text: “acute intravenous administration of synthetic DSIP, 25 nmoles/kg b.wt, on disturbed human sleep were tested in 6 middle-aged chronic insomniacs” | Human study | single dose | one night | 6 middle-aged chronic insomniacs (6) |
| 25 nmol/kgChronic insomnia, double-blind crossover against placebo; intravenousSource text: “DSIP in a dose of 25 nmol/kg or a placebo was administered i.v. during four nights using a double-blind crossover design.” | Human study | once a night | four nights | insomniac patients; number not given in the abstract (4) |
| 25 nmol/kgChronic insomnia, double-blind matched-pairs parallel groups; intravenous, given in the afternoon before the night recordedSource text: “half of the patients received intravenously 25 nmol/kg body weight DSIP, and half of the patients a glucose solution (placebo)” | Human study | once a day | 3 days | 16 chronic insomniac patients, half on DSIP and half on a glucose placebo (1) |
| 25 nmol/kgHormone study, randomized double-blind crossover against saline; intravenousSource text: “received a single dose of synthetic delta sleep-inducing peptide (DSIP) (25 nmol/kg BW) or saline intravenously” | Human study | single dose | one day | 11 healthy men aged 25 to 39 (7) |
| 3 mg totalHormone study; intravenous infusion running from 30 minutes before to 90 minutes after a CRH injectionSource text: “DSIP (total doses of 3 and 4 mg, respectively, vs. placebo) was infused intravenously between 30 min prior to and 90 min after CRH injections.” | Human study | single infusion | about 2 hours | healthy young men, 5 in each condition (5) |
| 4 mg totalHormone study; intravenous infusion, around a CRH injection in one experiment and around a meal in anotherSource text: “DSIP (4 mg, also administered as intravenous infusion) on meal-related ACTH and cortisol secretion was studied in another 10 men” | Human study | single infusion | about 2 hours in the CRH experiment | healthy young men: 5 in the CRH experiment, 10 in the meal experiment (5) |
| 25, 50 or 100 nmol/kgAdd-on to isoflurane anesthesia, randomized against saline; intravenous bolus, given once awake and once after inductionSource text: “receive one of three intravenous bolus doses of DSIP (Clinalfa) at 25, 50 or 100 nmol kg(-1)” | Human study | two doses, one awake and one after induction of anesthesia | one day | 12 women (ASA I or II) received DSIP; 12 received saline (3) |
| 0.0003 g (0.3 mg)Diabetic retinopathy, a product called deltalicin; given into the nose (intranasal), not injectedSource text: “Treatment with deltalicin (daily dose of 0.0003 g of delta sleep-inducing peptide intranasally for two months)” | Human study | daily dose | two months | insulin-dependent patients with diabetic retinopathy; 15 such patients were in the study (8) |
How to reconstitute DSIP
DSIP comes as a dry powder (5 mg vials). Reconstituting it means adding bacteriostatic water so it can be drawn into a syringe. The water does not change how much DSIP is in the vial, only how strong each mL is, so it decides how many syringe units a dose takes.
| Vial | Water | Strength | What 10 units holds | Doses between 5 and 100 units |
|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 500 mcg in every 10 units | 250 mcg to 5 mg |
| 5 mg | 2 mL | 2.5 mg/mL | 250 mcg in every 10 units | 125 mcg to 2.5 mg |
| 5 mg | 3 mL | 1.667 mg/mL | 167 mcg in every 10 units | 83 mcg to 1.67 mg |
The last column is the range of doses that land between the 5 unit mark (small marks are hard to read) and the 100 unit mark of a 1 mL U-100 syringe for that mix. All of it is arithmetic.
Reconstitution steps
- Wash your hands, work in a clean area and set out the DSIP vial, bacteriostatic water, a sterile syringe, alcohol pads and a sharps container (11).
- Check the vial and the water: right product, in date, intact cap (11).
- Wipe both rubber tops with an alcohol pad and let them dry (11).
- Draw the water amount you picked from the table into the syringe.
- Push the needle through the DSIP vial stopper and let the water in slowly.
- Move the vial in a circle until the powder is fully dissolved. Do not shake it (12).
- Check the liquid. MedlinePlus says not to use it if it has changed color, has floating pieces or is cloudy (11).
- Write the date you mixed it on the vial (11), and note the water amount so every later draw uses the same numbers.
After mixing
No published storage data exists for mixed DSIP; the bacteriostatic water label says not to store a mixed drug unless its maker says you can (10).
For any other vial size, water amount or dose, use the DSIP reconstitution calculator.
What the DSIP research found
In people
- Small human studyFirst human study (6 healthy volunteers): in about two hours after a morning infusion, total sleep time was 59% higher than after placebo. (2)Source text: “sleep increased by 59% (median of total sleep time) within a 130-min interval after the treatment as compared with placebo”
- Small human study6 chronic insomniacs, one intravenous dose: longer sleep with fewer interruptions. (6)Source text: “longer sleep duration and a higher quality of sleep with fewer interruptions”
- Small human study14 chronic insomniacs, placebo-controlled and double-blind over 7 nights: night sleep and daytime alertness improved. The abstract gives no dose. (13)Source text: “The treatment substantially improved night sleep with the first and additionally with repeated doses.”
- Small human studyDouble-blind crossover in insomniac patients over four nights: sleep time rose, but the same differences from placebo were already there at baseline, and the authors judged the benefit to be of little clinical significance. (4)Source text: “It can be concluded that sleep improvement under DSIP treatment is of little clinical significance.”
- Randomized trialDouble-blind study in 16 chronic insomniacs: slightly better sleep efficiency and shorter time to fall asleep, no change in how patients rated their sleep. The authors concluded that a major benefit was unlikely. (1)Source text: “short-term treatment of chronic insomnia with DSIP is not likely to be of major therapeutic benefit”
- Randomized trial11 healthy men, randomized crossover: plasma ACTH fell for at least 3 hours after an intravenous dose, while cortisol did not change. (7)Source text: “A significant reduction of ACTH-like immunoreactivity (ACTH-LI) in plasma was detected for at least 3 hr after the DSIP injection”
- Small human studyA later study in healthy men found no effect of DSIP infusion on ACTH or cortisol after CRH or after a meal. (5)Source text: “Our data do not support an inhibitory role of DSIP on ACTH and cortisol secretion in man.”
- Randomized trialGiven with isoflurane anesthesia to 12 women, DSIP did not deepen anesthesia. The authors concluded it made it lighter. (3)Source text: “DSIP probably reduced parasympathetic tone and decreased (lightened) the depth of anaesthesia measured using BIS.”
- Small human studyDiabetic retinopathy, two months of DSIP into the nose: visual evoked potential measures improved. Small study without a described placebo group. (8)Source text: “decreased the latent period and led to less pronounced depression of VEP amplitude in patients with diabetic retinopathy”
In animals and in the lab
These results come from animals or cells. They show what researchers are looking at, not what DSIP does in people.
- Lab studyIn human and rat blood in the laboratory DSIP broke down, and the authors put the rapid disappearance of injected DSIP from blood down to that breakdown. (14)Source text: “the rapid disappearance of injected DSIP in blood was due to degradation”
DSIP dosage and side effects
What labels and human studies report. A short or small study can miss rare side effects, so an empty list is not proof of safety.
- The first human study reported that a single slow intravenous infusion was well tolerated, with no side effects seen in 6 volunteers. (2)
- In 6 insomniacs there was no daytime sedation; a slight arousing effect was noted in the first hour after injection. (6)
- During isoflurane anesthesia, DSIP significantly increased heart rate and reduced heart rate variability. (3)
- FDA says it has not identified safety information for emideltide and names immune reactions and peptide impurities as possible risks of compounded product. (15)
Injecting under the skin
General steps for an injection under the skin, from MedlinePlus (16). Labels for approved products give their own instructions, which come first.
- Pick a site: the belly (below the ribs, above the hip bones and at least 2 inches from the belly button), the outer upper thigh, or the back or side of the upper arm.
- Move to a new spot each time, at least 1 inch from the last one. MedlinePlus says this keeps the skin healthy and helps the body absorb the medicine.
- Wash your hands with soap and running water for at least 1 minute, dry them, then clean the skin with an alcohol pad and let it dry.
- Pinch about an inch of skin and fat, put the needle in quickly at 90 degrees (45 degrees if there is little fat), let go of the skin and push the plunger all the way.
- Pull the needle out, put it straight into a sharps container, and press clean gauze on the spot for a few seconds. Never reuse a needle or syringe.
- Some soreness is expected. MedlinePlus says to contact a health care provider for signs of infection such as redness, swelling, red streaks or fever.
To draw the right amount, use the DSIP calculator and the drawing steps on that page.
Is DSIP legal in the US and Canada?
FDA page content current as of 2026-04-22. openFDA searches of Drugs@FDA and of drug labels for emideltide and for delta sleep-inducing peptide returned no match on 2026-10-10.
Advisory dated 2026-04-09. Drug Product Database searches for emideltide, dsip and delta sleep returned no rows on 2026-10-10 (S14).
What is still unknown
- Almost all human dosing on record was intravenous, mostly set in nanomoles per kilogram, in studies of 6 to 24 people published between 1981 and 2009. No human study of injection under the skin was found.
- Doses given in nmol/kg are kept in those units here and are not converted to mg.
- The results conflict. The early studies, which share a first author, reported better sleep (S2, S3, S4); two later double-blind studies in insomnia concluded the benefit was slight or unlikely to matter (S5, S6).
- In an anesthesia study DSIP raised heart rate and made anesthesia lighter, not deeper (S9).
- Not an approved medicine in the US or Canada as of the check date. Health Canada lists DSIP among unauthorized injectable peptide drugs it has seized (S13).
- FDA compounding status: on the FDA page current as of 2026-04-22, DSIP is not in the table of substances now in category 2. It is in a separate list of substances that were in category 2 and were then withdrawn by their nominators (S12).
- No human study of DSIP injected under the skin or into muscle. A PubMed search for those routes in people returned one intranasal letter with no abstract and one mouse study.
- No human half-life figure. One laboratory study attributes the rapid disappearance of injected DSIP from blood to breakdown but gives no number in its abstract (S11), so half_life is left out.
- The 7-night insomnia study (S4) gives no dose in its abstract.
- No DSIP trial registered on ClinicalTrials.gov: searches for DSIP, emideltide and delta sleep-inducing peptide as the intervention returned no trial of the peptide.
- No approved label, so no official dose, contraindications, interaction list or storage instructions.
- Not named on the WADA Prohibited List (page checked 2026-10-10, S15). The list also has an open class, S0, for substances with no current approval by any governmental health authority for human therapeutic use; whether it applies to this compound was not determined here.
DSIP dosage questions
What DSIP dosage was used in human studies?
25 nmol/kg, single dose; 25 nmol/kg, single dose; 25 nmol/kg, once a night; 25 nmol/kg, once a day. Each is listed with its study on this page.
How often was DSIP given?
In the sources on this page: daily dose; once a day; once a night; single dose; single infusion.
How long were DSIP courses?
In the sources on this page: 3 days; about 2 hours; about 2 hours in the CRH experiment; four nights; one day.
Is DSIP approved?
Not FDA approved. FDA lists emideltide (DSIP) among bulk substances that were in compounding category 2 and whose nominations were then withdrawn. No DSIP or emideltide product in the Health Canada Drug Product Database. Health Canada names DSIP among unauthorized injectable peptide drugs it has seized.
What side effects of DSIP have been reported?
The first human study reported that a single slow intravenous infusion was well tolerated, with no side effects seen in 6 volunteers. In 6 insomniacs there was no daytime sedation; a slight arousing effect was noted in the first hour after injection.
How many units of DSIP do I draw?
Use the DSIP calculator: pick your vial, water and dose, and it gives the units on a U-100 insulin syringe.
Sources
- Bes F et al. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology 1992. PubMed 1299794
- Schneider-Helmert D et al. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol 1981. PubMed 6895513
- Pomfrett CJ et al. Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia. Eur J Anaesthesiol 2009. PubMed 19142086
- Monti JM et al. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. Int J Clin Pharmacol Res 1987. PubMed 3583493
- Spath-Schwalbe E et al. Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion. Psychoneuroendocrinology 1995. PubMed 7777652
- Schneider-Helmert D et al. The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep. Experientia 1981. PubMed 7028502
- Bjartell A et al. Reduction of immunoreactive ACTH in plasma following intravenous injection of delta sleep-inducing peptide in man. Psychoneuroendocrinology 1989. PubMed 2554357
- Kresiun NV et al. [Using deltalicin for the treatment of patients with diabetic retinopathy]. Eksp Klin Farmakol 2014. PubMed 25739189
- Schoenenberger GA et al. The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptide. Pflugers Arch 1978. PubMed 568769
- Bacteriostatic Water for Injection, USP (Hospira) label. DailyMed
- MedlinePlus, Drawing medicine out of a vial (reviewed 14 Jan 2026). medlineplus.gov
- Egrifta WR (tesamorelin) US prescribing information, section 2.2. DailyMed
- Schneider-Helmert D Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. Eur Neurol 1987. PubMed 3622582
- Graf MV et al. Degradation and aggregation of delta sleep-inducing peptide (DSIP) and two analogs in plasma and serum. Peptides 1987. PubMed 3628078
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. fda.gov
- MedlinePlus, Subcutaneous (SQ) injections. medlineplus.gov
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you. recalls-rappels.canada.ca
Facts checked 10 Oct 2026 against the sources above. This page reports what labels and published studies used. It is not medical advice: talk to a licensed prescriber before you start, stop or change anything.